Table of Contents

Scleroderma

Introduction

described at drugs.com with

guide to current approach

Rheumatology definition

Evidence of infectious cause

In the September 2009 edition of the Annals of the New York Academy of the Sciences, a study was published that had evaluated, “… the potential role infections may have on the pathogenesis of systemic scleroderma.” In this study, researchers studied serological samples taken from eighty patients of European origin with the disease (as compared to two-hundred and ninety-six healthy controls) to assess the presence of antibodies for a number of infectious agents, including, “… hepatitis B virus, hepatitis C virus, toxoplasmosis, rubella, CMV, EBV, and Treponema pallidum.” Data collected from the study revealed, “… that antibodies against CMV, HBV, and toxoplasmosis were detected more often in patients with SSc.“ Study authors concluded, “This association implies that infectious agents may have a role in disease pathogenesis and expression.”

Source:

https://www.ncbi.nlm.nih.gov/pubmed/19758208

Management

Hypodermitis sclerodermiformis. Successful treatment with ultrasound. 1)

A Guide to Antibiotic Therapy

Bacterial Infection as the Cause of Scleroderma:

Dr. Cantwell reported finding pleomorphic bacteria in the skin of scleroderma patients over 20 years ago. 2)

Member joanbpass: Scleroderma: Assessing my improvements

Recent research

Assessment and management of patients with juvenile localised scleroderma 3)

Intriguing Relationships Between Cancer and Systemic Sclerosis: Role of the Immune System and Other Contributors. 4)

Autologous Stem-Cell Transplantation for Severe Scleroderma.5)

Position Statement from the American Society for Blood and Marrow Transplantation 6)

Short-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival 7)

There are many factors to be taken under consideration with SSc onset, although a strong correlation has been established for only a few. The most distinct factors are: crystalline silica and organic solvents (such as white spirit, aromatic, aliphatic-chain, chlorinated solvents, ketones, welding fumes). For other factors, which include abstestos, air pollution, other chemicals, silicone breast implants, tobacco smoking, drug reactions, diet influence and exposure to heavy metals, the jury is still out, and their position in SSc onset needs further studies. 8)

Data suggest naltrexone could be helpful in the treatment of pruritus and a variety of inflammatory and acantholytic skin diseases refractory to other treatments. At higher doses, liver function tests should be monitored on a periodic basis.9)

Genetic overlap “we performed a cross-disease meta-analysis of Immunochip data from 37,159 patients diagnosed with a seropositive autoimmune disease (11,489 celiac disease (CeD), 15,523 rheumatoid arthritis (RA), 3477 systemic sclerosis (SSc), and 6670 type 1 diabetes (T1D)) and 22,308 healthy controls of European origin using the R package ASSET.” 10)

To determine whether lung involvement is related to microvascular perturbations, nailfold videocapillaroscopy (NVC) was performed in patients with systemic sclerosis. A good correlation was observed between distinctive quantitative and qualitative NVC features with lung functional parameters such as FVC and DLCO. It is suggested that vasculopathy could play a role 11)

The association between cocaine abuse and systemic sclerosis (SSc) is rarely described. a 27 year-old male patient presented limited SSc with skin ulcers and digital gangrene, rapidly evolving to death due to massive intestinal hemorrhage. 12)

Assessment of associations of nailfold videocapillaroscopy (NVC) scleroderma patterns ('early', 'active' and 'late') with future severe clinical involvement in a systemic sclerosis (SSc) population. 13)

This capillaroscopic score may represent a feasible and simple tool in SSc patients' assessment. The routinely use of this parameter might permit to recognize and to preventively treat SSc patients at high risk to develop digital ulcers. 14)

Interview

Alan Cantwell

scleroderma

Read the interview


Interviews of patients with other diseases are also available.

Patient

1)
Rowe L, Cantwell AJ. Hypodermitis sclerodermiformis. Successful treatment with ultrasound. Arch Dermatol. 1982 May;118(5):312-4. doi: 10.1001/archderm.118.5.312.
[PMID: 7082022] [DOI: 10.1001/archderm.118.5.312]
2)
Cantwell ARJ. Histologic observations of pleomorphic, variably acid-fast bacteria in scleroderma, morphea, and lichen sclerosus et atrophicus. Int J Dermatol. 1984 Jan-Feb;23(1):45-52. doi: 10.1111/j.1365-4362.1984.tb05662.x.
[PMID: 6724767] [DOI: 10.1111/j.1365-4362.1984.tb05662.x]
3)
Lythgoe H, Almeida B, Bennett J, Bhat C, Bilkhu A, Brennan M, Deepak S, Dawson P, Eleftheriou D, Harrison K, Hawley D, Heaf E, Leone V, Long E, Maltby S, McErlane F, Rafiq N, Ramanan AV, Riley P, Rangaraj S, Varnier G, Wilkinson N, Pain CE. Multi-centre national audit of juvenile localised scleroderma: describing current UK practice in disease assessment and management. Pediatr Rheumatol Online J. 2018 Dec 18;16(1):80. doi: 10.1186/s12969-018-0295-0.
[PMID: 30563543] [PMCID: 6299547] [DOI: 10.1186/s12969-018-0295-0]
4)
Maria ATJ, Partouche L, Goulabchand R, Rivière S, Rozier P, Bourgier C, Le Quellec A, Morel J, Noël D, Guilpain P. Intriguing Relationships Between Cancer and Systemic Sclerosis: Role of the Immune System and Other Contributors. Front Immunol. 2019 Jan 10;9:3112. doi: 10.3389/fimmu.2018.03112. eCollection 2018.
[PMID: 30687318] [PMCID: 6335319] [DOI: 10.3389/fimmu.2018.03112]
5)
Sullivan KM, Goldmuntz EA, Keyes-Elstein L, McSweeney PA, Pinckney A, Welch B, Mayes MD, Nash RA, Crofford LJ, Eggleston B, Castina S, Griffith LM, Goldstein JS, Wallace D, Craciunescu O, Khanna D, Folz RJ, Goldin J, St Clair EW, Seibold JR, Phillips K, Mineishi S, Simms RW, Ballen K, Wener MH, Georges GE, Heimfeld S, Hosing C, Forman S, Kafaja S, Silver RM, Griffing L, Storek J, LeClercq S, Brasington R, Csuka ME, Bredeson C, Keever-Taylor C, Domsic RT, Kahaleh MB, Medsger T, Furst DE, SCOT Study Investigators. Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma. N Engl J Med. 2018 Jan 4;378(1):35-47. doi: 10.1056/nejmoa1703327.
[PMID: 29298160] [PMCID: 5846574] [DOI: 10.1056/nejmoa1703327]
6)
Sullivan KM, Majhail NS, Bredeson C, Carpenter PA, Chatterjee S, Crofford LJ, Georges GE, Nash RA, Pasquini MC, Sarantopoulos S, Storek J, Savani B, St Clair EW. Systemic Sclerosis as an Indication for Autologous Hematopoietic Cell Transplantation: Position Statement from the American Society for Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 2018 Oct;24(10):1961-1964. doi: 10.1016/j.bbmt.2018.06.025. Epub 2018 Jun 25.
[PMID: 29953945] [PMCID: 6239926] [DOI: 10.1016/j.bbmt.2018.06.025]
7)
Volkmann ER, Tashkin DP, Sim M, Li N, Goldmuntz E, Keyes-Elstein L, Pinckney A, Furst DE, Clements PJ, Khanna D, Steen V, Schraufnagel DE, Arami S, Hsu V, Roth MD, Elashoff RM, Sullivan KM, SLS I and SLS II study groups. Short-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival in two independent clinical trial cohorts. Ann Rheum Dis. 2019 Jan;78(1):122-130. doi: 10.1136/annrheumdis-2018-213708. Epub 2018 Nov 8.
[PMID: 30409830] [PMCID: 6311344] [DOI: 10.1136/annrheumdis-2018-213708]
8)
Walecka I, Roszkiewicz M, Malewska A. Potential occupational and environmental factors in SSc onset. Ann Agric Environ Med. 2018 Dec 19;25(4):596-601. doi: 10.26444/aaem/75894. Epub 2017 Jul 14.
[PMID: 30586984] [DOI: 10.26444/aaem/75894]
9)
Lee B, Elston DM. The uses of naltrexone in dermatologic conditions. J Am Acad Dermatol. 2019 Jun;80(6):1746-1752. doi: 10.1016/j.jaad.2018.12.031. Epub 2018 Dec 21.
[PMID: 30582992] [DOI: 10.1016/j.jaad.2018.12.031]
10)
Márquez A, Kerick M, Zhernakova A, Gutierrez-Achury J, Chen W, Onengut-Gumuscu S, González-Álvaro I, Rodriguez-Rodriguez L, Rios-Fernández R, González-Gay MA, Mayes MD, Raychaudhuri S, Rich SS, Wijmenga C, Martín J, Type 1 Diabetes Genetics Consortium. Meta-analysis of Immunochip data of four autoimmune diseases reveals novel single-disease and cross-phenotype associations. Genome Med. 2018 Dec 20;10(1):97. doi: 10.1186/s13073-018-0604-8.
[PMID: 30572963] [PMCID: 6302306] [DOI: 10.1186/s13073-018-0604-8]
11)
Guillén-Del-Castillo A, Simeón-Aznar CP, Callejas-Moraga EL, Tolosa-Vilella C, Alonso-Vila S, Fonollosa-Pla V, Selva-O'Callaghan A. Quantitative videocapillaroscopy correlates with functional respiratory parameters: a clue for vasculopathy as a pathogenic mechanism for lung injury in systemic sclerosis. Arthritis Res Ther. 2018 Dec 19;20(1):281. doi: 10.1186/s13075-018-1775-9.
[PMID: 30567570] [PMCID: 6299957] [DOI: 10.1186/s13075-018-1775-9]
12)
Andreussi R, Silva LMB, da Silva HC, Luppino-Assad AP, Andrade DCO, Sampaio-Barros PD. Systemic sclerosis induced by the use of cocaine: is there an association?. Rheumatol Int. 2019 Feb;39(2):387-393. doi: 10.1007/s00296-018-4227-6. Epub 2018 Dec 15.
[PMID: 30554308] [DOI: 10.1007/s00296-018-4227-6]
13)
Smith V, Decuman S, Sulli A, Bonroy C, Piettte Y, Deschepper E, de Keyser F, Cutolo M. Do worsening scleroderma capillaroscopic patterns predict future severe organ involvement? a pilot study. Ann Rheum Dis. 2012 Oct;71(10):1636-9. doi: 10.1136/annrheumdis-2011-200780. Epub 2012 Mar 8.
[PMID: 22402146] [DOI: 10.1136/annrheumdis-2011-200780]
14)
Sebastiani M, Manfredi A, Colaci M, Giuggioli D, La Sala R, Elkhaldi N, Antonelli A, Ferri C. [Correlation of a quantitative videocapillaroscopic score with the development of digital skin ulcers in scleroderma patients]. Reumatismo. 2008 Jul-Sep;60(3):199-205. doi: 10.4081/reumatismo.2008.199.
[PMID: 18854881] [DOI: 10.4081/reumatismo.2008.199]